These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 16849553)
1. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein. Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553 [TBL] [Abstract][Full Text] [Related]
2. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Kawakubo H; Carey JL; Brachtel E; Gupta V; Green JE; Walden PD; Maheswaran S Oncogene; 2004 Oct; 23(50):8310-9. PubMed ID: 15378000 [TBL] [Abstract][Full Text] [Related]
3. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Donato LJ; Suh JH; Noy N Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770 [TBL] [Abstract][Full Text] [Related]
4. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection]. Mrhalová M; Kodet R; Strnad P Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908 [TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778 [TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins. Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578 [TBL] [Abstract][Full Text] [Related]
7. Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor alpha-mediated transcription. Zhu J; Sen S; Wei C; Frazier ML Int J Oncol; 2010 Jan; 36(1):39-48. PubMed ID: 19956831 [TBL] [Abstract][Full Text] [Related]
8. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Qiu C; Shan L; Yu M; Snyderwine EG Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090 [TBL] [Abstract][Full Text] [Related]
9. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression. Yang C; Trent S; Ionescu-Tiba V; Lan L; Shioda T; Sgroi D; Schmidt EV Cancer Res; 2006 Dec; 66(24):11649-58. PubMed ID: 17178859 [TBL] [Abstract][Full Text] [Related]
11. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155 [TBL] [Abstract][Full Text] [Related]
13. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma. Lim SC Oncol Rep; 2003; 10(5):1241-9. PubMed ID: 12883688 [TBL] [Abstract][Full Text] [Related]
14. Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-alpha expression in human breast cancer. Kronblad A; Helczynska K; Nielsen NH; Påhlman E; Emdin S; Påhlman S; Landberg G In Vivo; 2003; 17(4):311-8. PubMed ID: 12929585 [TBL] [Abstract][Full Text] [Related]
15. Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells. Kwon YK; Jun JM; Shin SW; Cho JW; Suh SI Int J Oncol; 2005 Jun; 26(6):1597-603. PubMed ID: 15870875 [TBL] [Abstract][Full Text] [Related]
16. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells. Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097 [TBL] [Abstract][Full Text] [Related]
17. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Cho EY; Choi YL; Han JJ; Kim KM; Oh YL Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636 [TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells. Kilker RL; Hartl MW; Rutherford TM; Planas-Silva MD J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):63-71. PubMed ID: 15544931 [TBL] [Abstract][Full Text] [Related]
19. [Expression of ER, PR and cyclin D1 in breast infiltrating ductal carcinoma and their clinicopathological significance]. Wang ZB; Zhao P; Liu M; Li XH Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):514-7. PubMed ID: 15949328 [TBL] [Abstract][Full Text] [Related]
20. [Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer]. Song YC; Fu SD; Wen XP; Ma ZH; Dang CX Ai Zheng; 2007 Jul; 26(7):709-14. PubMed ID: 17626745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]